Table 1.

PBX3-targetting microRNAs (miRs) in cancer. AML, acute myeloid leukemia; HCC, hepatocellular carcinoma; lncRNA, long non-coding RNA; MAP3K2, mitogen-activated protein kinase kinase2; MM, multiple myeloma; MMP11, matrix metalloprotease 11; UTR, untranslated region.

miR	Cancers	Binding/Other Targets/Regulation	Ref.
miR-let-7d	Prostate cancer	Upregulated by androgen	[14]
miR-let-7c	Colorectal cancer	Binds 3’UTR, also targets MMP11	[17]
miR-let-7b	Glioma	Binds 3’UTR	[18]
miR-181	AML	Binds 3’UTR	[19]
miR-129-5p	Pancreatic cancer	Binds 3’UTR	[20]
miR-495	AML and melanoma	Binds 3’UTR, also targets MEIS1	[21]
miR-200b	HCC and breast cancer	Binds 3’UTR	[23,24]
miR-222	HCC	Binds 3’UTR	[24]
miR-424	HCC	Binds 3’UTR	[24]
miR-320a	MM, gastric cancer, and HCC	Binds 3’UTR	[25,26,27]
miR-33a-3p	HCC	Binds 3’UTR	[28]
miR-497	MM	Binds 3’UTR	[29]
miR-144-3p	Gastric cancer	Binds 3’UTR	[30]
miR-98	Glioma	Binds 3’UTR	[31]
miR-144	Lung cancer, HCC	Binds 3’UTR, also binds the lncRNA UCA1	[32,33]
miR-302a	HCC	Binds 3’UTR, also targets MAP3K2	[34]
miR-526b	Cervical cancer	Binds 3’UTR	[35]